Orchids Paper Products Co. (DE) (TIS) Drops 5.89% on February 04

Equities Staff  |

Orchids Paper Products Co. (DE) (TIS) was one of the Russell 2000's biggest losers for Thursday February 04 as the stock slid 5.89% to $27.30, a loss of $-1.71 per share. Starting at an opening price of $27.25 a share, the stock traded between $25.30 and $27.70 over the course of the trading day. Volume was 319,571 shares over 2,365 trades, against an average daily volume of 57,836 shares and a total float of 10.27 million.

The losses send Orchids Paper Products Co. (DE) down to a market cap of $280.34 million. In the last year, Orchids Paper Products Co. (DE) has traded between $32.50 and $21.42, and its 50-day SMA is currently $29.43 and 200-day SMA is $26.06.

The stock has a P/E Ratio of 22.

Orchids Paper Products Co manufactures bulk tissue paper, known as parent rolls, and convert parent rolls into a line of tissue products, including paper towels, bathroom tissue and paper napkins, for the consumer, or 'at-home,' market.

Orchids Paper Products Co. (DE) is based out of Pryor, OK and has some 313 employees. Its CEO is Jeffrey S. Schoen.

For a complete fundamental analysis analysis of Orchids Paper Products Co. (DE), check out Equities.com’s Stock Valuation Analysis report for TIS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer



Symbol Last Price Change % Change










World Economic Forum at Davos 2019 - Dr Oliver Krause Founder Untitled Inc Part 2

Matt Bird sits down with Dr Oliver Krause, Founder Untitled Inc, in part 2 of this 2 part interview at the World Economic Forum at Davos 2019

Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…